Josef Micaiah Hannah, DO
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Office
- 1
- Since medical school
- 13 years
- Graduated 2013
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hannah’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$65,005
Medicare paid this office $65,005 for 164 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 74 | $26,408 | $159 |
| Return visit (30+ min) | 57 | $14,670 | $115 |
| New patient visit (60+ min) | 55 | $10,287 | $187 |
| Short return visit (20+ min) | 36 | $5,737 | $84 |
| New patient visit (45+ min) | 29 | $4,364 | $150 |
Who their Medicare patients are
164 Original Medicare patients in 2024. Average age 75 · Under 65 12% · 85 and older 19% · Women 60% · Also on Medicaid 24% · Health risk score 3.16. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 71% · Cancer 51% · Depression 39% · Chronic kidney disease 36% · Diabetes 28% · Coronary heart disease 27% · Heart failure 27% · COPD 26% · Atrial fibrillation 24% · Dementia 17% · Stroke 15%.
The office billed $290,682, Medicare allowed $85,408 and paid $65,005; for 492 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 164 | 492 | 75 | 3.16 | $290,682 | $65,005 |
| 2023 | 144 | 713 | 75 | 2.94 | $299,547 | $68,413 |
| 2022 | 147 | 585 | 74 | 2.71 | $348,998 | $61,324 |
| 2021 | 122 | 394 | 74 | 2.90 | $287,565 | $45,504 |
| 2020 | 158 | 419 | 73 | 2.97 | $200,024 | $31,522 |
| 2019 | 151 | 289 | 73 | 2.78 | $52,232 | $21,162 |
| 2018 | 161 | 288 | 73 | 2.98 | $58,795 | $23,169 |
| 2017 | 46 | 96 | 74 | 2.60 | $26,853 | $7,309 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Long return visit (40+ min) | 86 | $38,066 | $155 |
| New patient visit (60+ min) | 53 | $9,986 | $188 |
| Return visit (30+ min) | 46 | $8,833 | $105 |
| Telehealth originating site facility fee | 102 | $6,106 | $22 |
| New patient visit (45+ min) | 12 | $1,786 | $149 |
| Short return visit (20+ min) | 17 | $1,777 | $81 |
2022: 8 services
| Long return visit (40+ min) | 64 | $20,179 | $142 |
| Long return visit (40+ min) | 51 | $12,301 | $124 |
| New patient visit (60+ min) | 51 | $8,858 | $174 |
| Return visit (30+ min) | 30 | $4,940 | $99 |
| Return visit (30+ min) | 31 | $3,722 | $83 |
| New patient visit (60+ min) | 15 | $2,503 | $167 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $2,486 | $96 |
| Telehealth originating site facility fee | 58 | $2,349 | $21 |
2021: 8 services
| Long return visit (40+ min) | 40 | $11,648 | $131 |
| Long return visit (40+ min) | 47 | $11,455 | $136 |
| Return visit (30+ min) | 36 | $6,411 | $90 |
| New patient visit (60+ min) | 21 | $3,911 | $186 |
| Return visit (30+ min) | 21 | $2,887 | $90 |
| New patient visit (60+ min) | 14 | $2,476 | $177 |
| New patient visit (45+ min) | 13 | $1,738 | $134 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,676 | $88 |
2020: 7 services
| Return visit (30+ min) | 47 | $7,193 | $71 |
| Long return visit (40+ min) | 41 | $6,273 | $101 |
| Short return visit (20+ min) | 28 | $2,297 | $47 |
| Return visit (30+ min) | 25 | $2,067 | $74 |
| Long return visit (40+ min) | 12 | $1,902 | $112 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,257 | $74 |
| Short return visit (20+ min) | 22 | $1,094 | $46 |
2019: 8 services
| Return visit (30+ min) | 40 | $5,436 | $69 |
| Long return visit (40+ min) | 32 | $4,027 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,952 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,626 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,463 | $122 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 29 | $1,400 | $35 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,164 | $90 |
| Short return visit (20+ min) | 13 | $824 | $46 |
2018: 10 services
| Long return visit (40+ min) | 38 | $5,088 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,183 | $94 |
| Return visit (30+ min) | 25 | $2,331 | $71 |
| New patient visit (60+ min) | 15 | $2,258 | $151 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,796 | $90 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 31 | $1,574 | $35 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,438 | $65 |
| New patient visit (45+ min) | 11 | $1,268 | $115 |
| Extended inpatient or observation hospital service, first hour | 11 | $1,255 | $84 |
| New patient visit (30+ min) | 16 | $1,044 | $65 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,150 | $93 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,166 | $90 |
| Extended inpatient or observation hospital service, first hour | 11 | $1,081 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $907 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $734 | $35 |
Medicaid work
$231 in 2023
Medicaid paid $231 for 14 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Telehealth originating site facility fee | 14 | $231 |
| 2023 | 14 | 1 | 12 | $231 |
Drugs they prescribed that Part D paid
$42,779
Pharmacies billed $42,779 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 45% of their Part D prescriptions (258 of 580) in 2024. A higher opioid share than 9 in 10 peers; the typical internal medicine clinician is at 1%. Long-acting opioids: 38% of their opioid prescriptions.
526 generic and 54 brand-name prescriptions · $42,779 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycontin | 15 | $21,566 | $1,438 |
| Zolpidem Tartrate Er | 13 | $1,885 | $145 |
| Hydrocodone-Acetaminophen | 39 | $1,757 | $45 |
| Lidocaine | 20 | $1,732 | $87 |
| Oxycodone | 54 | $1,594 | $30 |
See all 19 drugs
| Oxycontin | 15 | $21,566 | $1,438 |
| Zolpidem Tartrate Er | 13 | $1,885 | $145 |
| Hydrocodone-Acetaminophen | 39 | $1,757 | $45 |
| Lidocaine | 20 | $1,732 | $87 |
| Oxycodone | 54 | $1,594 | $30 |
| Fentanyl | 17 | $1,369 | $81 |
| Buprenorphine | 13 | $1,271 | $98 |
| Gabapentin | 64 | $1,195 | $19 |
| Pregabalin | 20 | $768 | $38 |
| Hydromorphone | 33 | $743 | $23 |
| Methadone | 39 | $635 | $16 |
| Morphine Sulfate Er | 13 | $438 | $34 |
| Morphine Sulfate | 17 | $373 | $22 |
| Oxycodone-Acetaminophen | 17 | $303 | $18 |
| Ondansetron Odt | 11 | $252 | $23 |
| Trazodone | 12 | $79 | $7 |
| Zolpidem | 12 | $75 | $6 |
| Diazepam | 18 | $54 | $3 |
| Lorazepam | 13 | $50 | $4 |
Year by year
| 2024 | 580 | 74 | 45% (258) | 9% | $42,779 |
| 2023 | 741 | 92 | 44% (327) | 8% | $54,319 |
| 2022 | 823 | 102 | 56% (457) | 18% | $83,298 |
| 2021 | 828 | 92 | 48% (396) | 16% | $65,964 |
| 2020 | 663 | 100 | 50% (328) | 22% | $64,191 |
| 2019 | 367 | 71 | 55% (202) | 23% | $47,889 |
| 2018 | 233 | 64 | 49% (114) | 21% | $150,090 |
| 2016 | 108 | 29 | None | 16% | $3,041 |
| 2015 | 103 | 38 | None | 29% | $10,178 |
| 2014 | 76 | 22 | None | 30% | $9,167 |
| 2013 | 16 | None | 0% (0) | None | $2,150 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Oxycontin | 25 | $23,105 | $924 |
| Xtampza Er | 11 | $6,946 | $631 |
| Pregabalin | 43 | $3,446 | $80 |
| Zolpidem Tartrate Er | 12 | $3,022 | $252 |
| Hydrocodone-Acetaminophen | 49 | $2,202 | $45 |
| Oxycodone | 75 | $2,063 | $28 |
| Gabapentin | 111 | $1,949 | $18 |
| Morphine Sulfate Er | 34 | $1,903 | $56 |
| Hydroxyzine | 14 | $835 | $60 |
| Hydromorphone | 27 | $832 | $31 |
| Methadone | 60 | $708 | $12 |
| Morphine Sulfate | 12 | $477 | $40 |
| Oxycodone-Acetaminophen | 15 | $378 | $25 |
| Clonazepam | 13 | $224 | $17 |
| Olanzapine | 11 | $221 | $20 |
| Trazodone | 21 | $183 | $9 |
| Prochlorperazine Maleate | 12 | $85 | $7 |
| Zolpidem | 15 | $76 | $5 |
| Tramadol | 11 | $63 | $6 |
| Diazepam | 23 | $59 | $3 |
2022: 19 drugs
| Oxycontin | 88 | $48,077 | $546 |
| Xtampza Er | 12 | $8,276 | $690 |
| Zolpidem Tartrate Er | 13 | $3,820 | $294 |
| Oxycodone | 127 | $2,914 | $23 |
| Pregabalin | 41 | $2,909 | $71 |
| Gabapentin | 96 | $2,425 | $25 |
| Morphine Sulfate Er | 52 | $1,811 | $35 |
| Hydromorphone | 46 | $1,052 | $23 |
| Hydrocodone-Acetaminophen | 29 | $1,001 | $35 |
| Ondansetron | 11 | $891 | $81 |
| Morphine Sulfate | 16 | $708 | $44 |
| Methadone | 45 | $575 | $13 |
| Oxycodone-Acetaminophen | 17 | $395 | $23 |
| Mirtazapine | 11 | $276 | $25 |
| Hydroxyzine | 12 | $245 | $20 |
| Tramadol | 18 | $220 | $12 |
| Clonazepam | 12 | $114 | $10 |
| Zolpidem | 18 | $73 | $4 |
| Diazepam | 26 | $43 | $2 |
2021: 18 drugs
| Oxycontin | 62 | $28,873 | $466 |
| Zolpidem Tartrate Er | 14 | $3,681 | $263 |
| Morphine Sulfate Er | 59 | $3,300 | $56 |
| Pregabalin | 35 | $3,187 | $91 |
| Oxycodone | 106 | $2,850 | $27 |
| Hydromorphone | 39 | $1,286 | $33 |
| Gabapentin | 67 | $1,091 | $16 |
| Mirtazapine | 22 | $995 | $45 |
| Morphine Sulfate | 27 | $692 | $26 |
| Ondansetron | 16 | $610 | $38 |
| Methadone | 34 | $357 | $11 |
| Hydrocodone-Acetaminophen | 15 | $357 | $24 |
| Methylphenidate | 13 | $264 | $20 |
| Tramadol | 20 | $252 | $13 |
| Lorazepam | 14 | $232 | $17 |
| Pantoprazole | 11 | $116 | $11 |
| Diazepam | 24 | $77 | $3 |
| Clonazepam | 11 | $60 | $5 |
2020: 16 drugs
| Oxycontin | 83 | $42,431 | $511 |
| Oxycodone | 102 | $2,028 | $20 |
| Dronabinol | 13 | $1,487 | $114 |
| Pregabalin | 26 | $1,045 | $40 |
| Hydromorphone | 25 | $960 | $38 |
| Morphine Sulfate Er | 35 | $845 | $24 |
| Ondansetron Odt | 15 | $597 | $40 |
| Gabapentin | 31 | $471 | $15 |
| Cyclobenzaprine | 14 | $319 | $23 |
| Methadone | 27 | $308 | $11 |
| Morphine Sulfate | 12 | $297 | $25 |
| Lorazepam | 25 | $256 | $10 |
| Tramadol | 14 | $224 | $16 |
| Hydrocodone-Acetaminophen | 12 | $221 | $18 |
| Diazepam | 27 | $80 | $3 |
| Pantoprazole | 12 | $46 | $4 |
2019: 9 drugs
| Oxycontin | 30 | $23,815 | $794 |
| Oxycodone | 57 | $2,334 | $41 |
| Fentanyl | 18 | $2,079 | $116 |
| Morphine Sulfate | 14 | $686 | $49 |
| Gabapentin | 22 | $616 | $28 |
| Morphine Sulfate Er | 17 | $581 | $34 |
| Hydromorphone | 11 | $360 | $33 |
| Methadone | 29 | $327 | $11 |
| Ondansetron Odt | 11 | $266 | $24 |
2018: 5 drugs
| Fentanyl | 17 | $1,770 | $104 |
| Oxycodone | 28 | $1,374 | $49 |
| Morphine Sulfate Er | 21 | $778 | $37 |
| Gabapentin | 18 | $431 | $24 |
| Morphine Sulfate | 16 | $290 | $18 |
2014: 1 drug
| Carvedilol | 11 | $229 | $21 |
Professional record
- NPI
- 1871931964
- Licence
- CA 20A14790
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RH0002X (207RH0002X)
- Mailing address
- 300 Pasteur Dr, Room Hc005 Mc 5277, Stanford, CA, 94305
- NPI first listed
- 2013-06-11
- NPI last updated
- 2024-04-17
- NPI record certified
- 2024-04-17
This is when the NPI record was last certified, not a medical board exam.